{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:47:01Z","timestamp":1794030421170,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03516"],"award-info":[{"award-number":["22H03516"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113891","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T23:45:47Z","timestamp":1666050347000},"page":"113891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Lysophospholipids\u2013potent candidates for brain food, protects neuronal cells against \u03b1-Synuclein aggregation"],"prefix":"10.1016","volume":"156","author":[{"given":"Tatsuya","family":"Karaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Haniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6469-920X","authenticated-orcid":false,"given":"Tamotsu","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2022.113891_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2022.113891_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.biopha.2022.113891_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3233\/JAD-170397","article-title":"Multiple system atrophy: an oligodendroglioneural synucleinopathy1","volume":"62","author":"Jellinger","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113891_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"alpha-synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2022.113891_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2022.113891_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11010026","article-title":"NRF2 activation ameliorates oxidative stress and improves mitochondrial function and synaptic plasticity, and in A53T alpha-synuclein hippocampal neurons","volume":"11","author":"Brandes","year":"2021","journal-title":"Antioxidants"},{"issue":"14","key":"10.1016\/j.biopha.2022.113891_bib7","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1111\/j.1742-4658.2010.07721.x","article-title":"Mysterious oligomerization of the amyloidogenic proteins","volume":"277","author":"Uversky","year":"2010","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.biopha.2022.113891_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092452","article-title":"Alpha-synuclein and lipids: the elephant in the room?","volume":"10","author":"Sarchione","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113891_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.578993","article-title":"Interaction of alpha-synuclein with lipids: mitochondrial cardiolipin as a critical player in the pathogenesis of Parkinson's disease","volume":"14","author":"Gilmozzi","year":"2020","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2022.113891_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2019.00175","article-title":"Lipids at the crossroad of alpha-synuclein function and dysfunction: biological and pathological implications","volume":"13","author":"Alza","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2022.113891_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562241","article-title":"The Role of Lipids in the Initiation of alpha-synuclein misfolding","volume":"8","author":"Kiechle","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2022.113891_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111064","article-title":"Oral administration of porcine liver decomposition product for 4 weeks enhances visual memory and delayed recall in healthy adults over 40 years of age: A randomized, double-blind, placebo-controlled study","volume":"141","author":"Matsuda","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113891_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrn2421","article-title":"Brain foods: the effects of nutrients on brain function","volume":"9","author":"Gomez-Pinilla","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2022.113891_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.5650\/jos.ess21069","article-title":"The combined effects of lysophospholipids against lipopolysaccharide-induced inflammation and oxidative stress in microglial cells","volume":"70","author":"Tsukahara","year":"2021","journal-title":"J. Oleo Sci."},{"issue":"3","key":"10.1016\/j.biopha.2022.113891_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jb\/mvab046","article-title":"Abundant oleoyl-lysophosphatidylethanolamine in brain stimulates neurite outgrowth and protects against glutamate toxicity in cultured cortical neurons","volume":"170","author":"Hisano","year":"2021","journal-title":"J. Biochem"},{"key":"10.1016\/j.biopha.2022.113891_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2020.11.119","article-title":"Structurally different lysophosphatidylethanolamine species stimulate neurite outgrowth in cultured cortical neurons via distinct G-protein-coupled receptors and signaling cascades","volume":"534","author":"Hisano","year":"2021","journal-title":"Biochem Biophys. Res Commun."},{"issue":"7","key":"10.1016\/j.biopha.2022.113891_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071827","article-title":"Autotaxin(-)Lysophosphatidic acid signaling in Alzheimer's disease","volume":"19","author":"Ramesh","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2022.113891_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuro.2008.02.011","article-title":"Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth","volume":"29","author":"Radio","year":"2008","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113891_bib19","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41598-020-60781-1","article-title":"Porcine liver decomposition product-derived lysophospholipids promote microglial activation in vitro","volume":"10","author":"Tsukahara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113891_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113608","article-title":"A systematic approach to quantitative Western blot analysis","volume":"593","author":"Pillai-Kastoori","year":"2020","journal-title":"Anal. Biochem"},{"issue":"9","key":"10.1016\/j.biopha.2022.113891_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094994","article-title":"Neurons and glia interplay in alpha-synucleinopathies","volume":"22","author":"Mavroeidi","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113891_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/pri.28125","article-title":"In vitro aggregation assays for the characterization of alpha-synuclein prion-like properties","volume":"8","author":"Narkiewicz","year":"2014","journal-title":"Prion"},{"issue":"2","key":"10.1016\/j.biopha.2022.113891_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","author":"Naiki","year":"1989","journal-title":"Anal. Biochem"},{"issue":"7","key":"10.1016\/j.biopha.2022.113891_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim Biophys. Acta"},{"issue":"40","key":"10.1016\/j.biopha.2022.113891_bib25","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2022.113891_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2022.113891_bib27","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bbamem.2012.05.019","article-title":"Polyphenolic compounds are novel protective agents against lipid membrane damage by alpha-synuclein aggregates in vitro","volume":"1818","author":"Caruana","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113891_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnins.2018.00301","article-title":"Chronic caffeine treatment protects against alpha-synucleinopathy by reestablishing autophagy activity in the mouse striatum","volume":"12","author":"Luan","year":"2018","journal-title":"Front Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2022.113891_bib29","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1021\/acschemneuro.5b00158","article-title":"Understanding caffeine's role in attenuating the toxicity of alpha-synuclein aggregates: implications for risk of Parkinson's disease","volume":"6","author":"Kardani","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2022.113891_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1248\/bpb.b22-00304","article-title":"The many roles of lysophospholipid mediators and Japanese contributions to this field","volume":"45","author":"Takagi","year":"2022","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2022.113891_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acschemneuro.1c00877","article-title":"Current progress in the development of probes for targeting alpha-synuclein aggregates","volume":"13","author":"Zeng","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113891_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovic","year":"2022","journal-title":"Cells"},{"issue":"45","key":"10.1016\/j.biopha.2022.113891_bib33","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2022.113891_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101419","article-title":"Structural and functional insights into alpha-synuclein fibril polymorphism","volume":"11","author":"Mehra","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2022.113891_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020324","article-title":"Production of recombinant alpha-synuclein: still no standardized protocol in sight","volume":"12","author":"Al-Azzani","year":"2022","journal-title":"Biomolecules"},{"issue":"48","key":"10.1016\/j.biopha.2022.113891_bib36","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1021\/acs.biochem.0c00725","article-title":"Purification of recombinant alpha-synuclein: a comparison of commonly used protocols","volume":"59","author":"Stephens","year":"2020","journal-title":"Biochemistry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:24:54Z","timestamp":1778243094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222201280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":36,"alternative-id":["S075333222201280X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113891","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysophospholipids\u2013potent candidates for brain food, protects neuronal cells against \u03b1-Synuclein aggregation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113891"}}